Lifespan Vision Ventures Leads Remedium Bio’s Series A Financing
Investment supports advancement of Remedium’s durable protein therapeutics platform toward first-in-human clinical development. NORWALK, Conn., Aug. 10, 2026 /PRNewswire/ — Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.’s (“Remedium”) $10 million Series A financing and has completed the round’s initial closing, with participation from Eli Lilly and Company (“Lilly”) and HKX […]
Lifespan Vision Ventures Leads Remedium Bio’s Series A Financing Read More »